# Occurrence of Dyskalemia With Treatment for Hypertension

Study · id `cardio:ct-nct05155436` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05155436](<https://clinicaltrials.gov/study/NCT05155436>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05155436

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1090 participants.

## Technical summary

Registry record NCT05155436. Allocation not applicable; no masking; primary purpose treatment. Start 2022-01-15 (actual); primary completion 2023-03-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1090 participants (enrolled count; ClinicalTrials.gov record NCT05155436, source copy `cardio:ctgov-nct05155436-2023-07-14`, retrieved 2026-10-26)
- Started: 2022-01-15 (actual) (ClinicalTrials.gov record NCT05155436, source copy `cardio:ctgov-nct05155436-2023-07-14`, retrieved 2026-10-26)
- Primary completion: 2023-03-31 (actual) (ClinicalTrials.gov record NCT05155436, source copy `cardio:ctgov-nct05155436-2023-07-14`, retrieved 2026-10-26)
- Completion: 2023-03-31 (actual) (ClinicalTrials.gov record NCT05155436, source copy `cardio:ctgov-nct05155436-2023-07-14`, retrieved 2026-10-26)
- Countries: Bangladesh (ClinicalTrials.gov record NCT05155436, source copy `cardio:ctgov-nct05155436-2023-07-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05155436-2023-07-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Occurrence of Dyskalemia With Treatment for Hypertension
- Acronym: OK
- Condition: Hypertension
- Condition: Potassium Imbalance
- Intervention (Drug): Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg
- Lead sponsor: National Heart Foundation of Bangladesh
- Lead sponsor class: OTHER
- Collaborator: National Heart Foundation Hospital and Research Institute of Bangladesh
- Collaborator class: UNKNOWN
- Collaborator: Johns Hopkins University
- Collaborator class: OTHER
- Collaborator: Resolve to Save Lives
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as a collaborator: Johns Hopkins University (`cardio:org-johns-hopkins-university`)

## Provenance

Content hash: 953ca7c8992960ba04893dc9d8ad2a7100ff4456b543b29a0495452039ba1fe7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
